Effects of Tumor Necrosis Factor Alpha Blocker Adalimumab in Experimental Spinal Cord Injury
Alp Özgün Börcek, Soner Çivi, Özgür Öcal, Özlem Gülbahar
J Korean Neurosurg Soc. 2015;57(2):73-76. Published online 2015 Feb 26 DOI: https://doi.org/10.3340/jkns.2015.57.2.73
Citations to this article as recorded by 
The Role of Tumor Necrosis Factor Following Spinal Cord Injury: A Systematic Review
Minna Christiansen Lund, Bettina Hjelm Clausen, Roberta Brambilla, Kate Lykke Lambertsen
Cellular and Molecular Neurobiology.2023; 43(3): 925. CrossRef
Early Decompression in Acute Spinal Cord Injury : Review and Update
Byung-Jou Lee, Je Hoon Jeong
Journal of Korean Neurosurgical Society.2023; 66(1): 6. CrossRef
The Antinociceptive Effect of Adalimumab, a TNF-Alpha Inhibitor, in a Mice Model of Inflammatory Pain
Mehmet ÖZ, Hasan ŞİMŞEK
Türk Doğa ve Fen Dergisi.2022; 11(3): 89. CrossRef
Novel inhibitors of Rho-kinase mediated neuroinflammatory pathways and their potential application in recovery of injured spinal cord
Mallikarjuna Nimgampalle, Hemanth Naick Banavath, Harshini Chakravarthy, Ambrish Saxena, Vasudharani Devanathan
Journal of Biomolecular Structure and Dynamics.2020; 38(16): 4669. CrossRef
Current Agents and Related Therapeutic Targets for Inflammation After Acute Traumatic Spinal Cord Injury
Ahmed Jorge, Tavis Taylor, Nitin Agarwal, D. Kojo Hamilton
World Neurosurgery.2019; 132: 138. CrossRef